Apocrine Carcinoma of the Breast: A Case Report and Review of the Literature
Article Sidebar
Main Article Content
Abstract
Background: Apocrine carcinoma of the breast is a rare and distinct subtype of invasive ductal carcinoma characterized histologically by large tumor cells with abundant eosinophilic granular cytoplasm and prominent nucleoli. Accurate diagnosis and immunohistochemical profiling are essential for distinguishing this entity from other breast cancer subtypes. Emerging evidence suggests a potential therapeutic role for androgen receptor (AR)-targeted treatments in managing this disease.
Case Presentation: The patient was a 55-year-old woman with no significant past medical history who presented for a routine physical examination. A screening mammogram revealed a 1.2 × 0.8 × 0.6 cm superficial mass in the upper outer quadrant of the right breast, along with scattered coarse microcalcifications. A core needle biopsy was performed, and histopathological analysis confirmed the diagnosis of apocrine carcinoma of the breast, a rare subtype of invasive ductal carcinoma. Immunohistochemistry (IHC) demonstrated strong androgen receptor (AR) positivity and negativity for estrogen receptor (ER), progesterone receptor (PR), and HER2.
Conclusions: Through a review of the current literature, we highlight the key histopathological, molecular, and clinical features of apocrine breast carcinoma.
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Clinical and Advanced Medicine (JCAM) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license allows anyone to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, as long as appropriate credit is given to the original author(s) and the source.
License link: https://creativecommons.org/licenses/by/4.0/